Article info

Download PDFPDF
Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxib
  1. Correspondence to:
 M J James
 Rheumatology Unit, Royal Adelaide Hospital, North Terrace, Adelaide, SA, Australia 5000; michael.jamesadelaide.edu.au
View Full Text

Citation

James MJ, Cleland LG
Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxib

Publication history

  • Accepted November 6, 2003
  • Revised November 2, 2003
  • First published April 13, 2004.
Online issue publication 
April 27, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Other content recommended for you